Literature DB >> 12512921

A study of bacteremia in febrile neutropenic patients at a tertiary-care hospital with special reference to anaerobes.

P Mathur1, R Chaudhry, L Kumar, A Kapil, B Dhawan.   

Abstract

Patients with hematological malignancies who are receiving chemotherapy suffer prolonged periods of neutropenia, which leads to a greater risk of infection and mortality. A prospective study was conduced to determine the incidence of bacteremia in patients of hematological malignancies over a 2-yr period. A total of 119 episodes of febrile neutropenia occurred among 96 consecutive patients, of which 35 episodes were associated with bacteremia. Forty-four percent of the isolated bacteria were Gram-positive aerobes and 46% were Gram-negative aerobes. Staphylococcus aureus, Enterococcus spp., and Escherichia coli were the most common isolates. Gram-negative bacteremia was associated with a higher mortality. Anaerobes accounted for 4.4% of all isolates. The episodes of anaerobic bacteremia were polymicrobial and had a fatal outcome. A high incidence of antimicrobial resistance among aerobic and anaerobic bacteria was also recorded. Compared to previous years, a shift from a predominating Gram-negative to a Gram-positive etiology was noted. The initial empiric antibiotic regimens should be based on a local knowledge of the most common causative microorganisms, their sensitivity pattern, and the outcome of bacteremia.

Entities:  

Mesh:

Year:  2002        PMID: 12512921     DOI: 10.1385/MO:19:4:267

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  9 in total

Review 1.  Present studies of therapy for anaerobic infections.

Authors:  S M Finegold; H M Wexler
Journal:  Clin Infect Dis       Date:  1996-12       Impact factor: 9.079

2.  Infections in acute myeloid leukemia. Study of 184 febrile episodes.

Authors:  L Kumar; V Kochupillai; R A Bhujwala
Journal:  J Assoc Physicians India       Date:  1992-01

3.  Comparison of risk factors and outcome in patients with Enterococcus faecalis vs Enterococcus faecium bacteraemia.

Authors:  J P Suppola; A Kuikka; M Vaara; V V Valtonen
Journal:  Scand J Infect Dis       Date:  1998

4.  A clinical study of adult leukaemias.

Authors:  A S Kasthuri; M P Jaiprakash; N K Panicker; M M Gupta; G S Rajoor; S K Basu; S Sambandam; I P Bhalla
Journal:  J Assoc Physicians India       Date:  1990-06

Review 5.  Anaerobic bacteremia.

Authors:  E J Goldstein
Journal:  Clin Infect Dis       Date:  1996-12       Impact factor: 9.079

Review 6.  Predominance of gram-positive microorganisms as a cause of septicemia in patients with hematological malignancies.

Authors:  M Rubio; L Palau; J R Vivas; E del Potro; J Diaz-Mediavilla; A Alvarez; R Martinez; J J Picazo
Journal:  Infect Control Hosp Epidemiol       Date:  1994-02       Impact factor: 3.254

7.  Septicemia in granulocytopenic patients: a shift in bacterial etiology.

Authors:  P J Johansson; E Sternby; B Ursing
Journal:  Scand J Infect Dis       Date:  1992

8.  The changing epidemiology of bacteremia in neutropenic children with cancer.

Authors:  V M Aquino; A Pappo; G R Buchanan; I Tkaczewski; M M Mustafa
Journal:  Pediatr Infect Dis J       Date:  1995-02       Impact factor: 2.129

Review 9.  Infections in neutropenic patients I: aetiology.

Authors:  P Engervall; M Björkholm
Journal:  Med Oncol       Date:  1995-12       Impact factor: 3.064

  9 in total
  5 in total

1.  Profile of infections and outcome in high-risk febrile neutropenia: experience from a tertiary care cancer center in India.

Authors:  Indranil Ghosh; Vinod Raina; Lalit Kumar; Atul Sharma; Sameer Bakhshi; Sanjay Thulkar; Arti Kapil
Journal:  Med Oncol       Date:  2011-02-20       Impact factor: 3.064

2.  Evaluation of predictors of adverse outcome in febrile neutropenic episodes in pediatric oncology patients.

Authors:  Meenakshi Bothra; Rachna Seth; Arti Kapil; S N Dwivedi; Shinjini Bhatnagar; Immaculata Xess
Journal:  Indian J Pediatr       Date:  2012-12-21       Impact factor: 1.967

3.  Emergence of MRSA in positive blood cultures from patients with febrile neutropenia--a cause for concern.

Authors:  Patrick G Morris; Tidi Hassan; Mairead McNamara; Astrid Hassan; Rebecca Wiig; Liam Grogan; Oscar S Breathnach; Edmond Smyth; Hilary Humphreys
Journal:  Support Care Cancer       Date:  2008-02-15       Impact factor: 3.603

4.  Febrile neutropenia: outline of management.

Authors:  Sapna Oberoi; Renu Suthar; Deepak Bansal; R K Marwaha
Journal:  Indian J Pediatr       Date:  2012-11-22       Impact factor: 5.319

5.  Bloodstream infections in febrile neutropenic patients at a tertiary cancer institute in South India: A timeline of clinical and microbial trends through the years.

Authors:  K Govind Babu; D Lokanatha; K C Lakshmaiah; M C Suresh Babu; Linu A Jacob; Gita R Bhat; Harsha Vardhana; Mahua Sinha; B R Vijaykumar; B G Sumati; R S Jayshree
Journal:  Indian J Med Paediatr Oncol       Date:  2016 Jul-Sep
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.